产后贫血

结论：rHuEPO治疗产后贫血是安全、有效的方法。

Conclusion rHuEPO therapy for postpartum anemia is effective and safe .

结果无论产前贫血组和产后贫血组血红蛋白均有较明显的回升（P<0.001）。

Results The hemoglobin level was increased significantly in the study group than control group both in the prenatal and postpartum anemia patients .

目的：为观察rHuEPO对产后贫血的治疗效果。

Ve To investigate the efficacy of rHuEPO in treating the anemia in postpartum .

结果：孕中期贫血导致孕晚期贫血、产后贫血、早产、过期妊娠、胎盘功能欠佳发生率增加（P<0.05）。

Rusults : Anemia in second trimester of pregnancy has brought the increasing incidence of anemia in third trimester , postpartum anemia , premature birth , prolonged pregnancy , depressed placenta function .

重型胎盘早剥者其围产儿死亡、新生儿窒息和产后贫血的发生率明显高于轻型胎盘早剥者，差异有统计学意义（P<0.05~0.01）。

The incidence rate of perinatal death , asphyxia of newborn , postpartum anemia in patient with severe placental abruption were much higher than that of mild placental abruption ( P < 0.05 ~ 0.01 ) .

结果：产后3天贫血的患病率41.8%，其中轻度53.3%，中度46.1%，重度0.6%。

Results : The prevalence of anemia at the 3rd day after delivery was 41.8 % , among which 53.3 % was mild anemia , 46.1 % was moderate anemia and 0.6 % was severe anemia .